Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 2, Randomized, Open Label Study of Figitumumab (CP-751,871) Plus Cisplatin (or Carboplatin) and Etoposide, Versus Cisplatin (or Carboplatin) a


Collapse Overview 
Collapse sponsor award id
A4021032 Phase 2


Collapse Biography 

Collapse Time 
Collapse start date
2010-09-09